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Abstract
Background: Due to their genetic proximity, chimpanzees share with human several diseases including
bacterial, fungal and viral infections, such as candidiasis, acquired immune deficiency syndrome (AIDS), Ebola
virus disease. However, in its natural environment, chimpanzees are tolerant to several pathogens including
simian immunodeficiency virus (SIV), virus related to human immunodeficiency virus (HIV) that contribute to
the emergence of opportunistic diseases such as microbial infections.
Methods: Twenty seven species of plants consumed by chimpanzees were evaluated for their antimicrobial
potential against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, Candida
tropicalis and Candida glabrata using the agar diffusion technique and micro-dilution in 96-well plates. In total
132 extracts (33 dichloromethane, 33 methanol, 33 ethyl acetate and 33 aqueous) were tested.
Results: The results showed that 24 extracts (18 %) showed activity against bacteria and 6 extracts (5 %) were active
against yeasts. The minimal inhibitory concentrations (MICs) values of active extracts ranged between 23 and 750 μg/
ml for bacteria and between 188 and 1500 μg/ml for yeasts.
Conclusion: Tristemma coronatum was the most promising on the studied microorganisms followed by Beilschmiedia
mannii. The extracts of the two plants indicated by chimpanzees have potential for antimicrobial use in human.
Keywords: Chimpanzee’s diet, Antimicrobial, Bacteria, Yeast, Beilschmiedia mannii, Tristemma coronatum, Ivory Coast
Background
The use of plants in herbal medicine is very old and is
experiencing a resurgence interest with the public [1].
According to World Health Organization (WHO), ap-
proximately, 75–80 % of the world’s population use plant
medicine either in part or entirely for their health and
care needs [2]. Chimpanzees are mainly frugivorous.
This practice seems to have a beneficial effect on their
health and well-being. Thus, it is worth exploring their
behavioral trend to self-medicate in order to identify
plants with therapeutic potential to fight certain human
diseases including bacteria and fungi. These diseases are
getting more common in humans with the development
of drug resistance.
Infectious diseases caused by bacteria and fungi affect
millions of people worldwide [3]. According to Soro
et al. [4], bacterial and fungal infections, especially can-
didiasis, are among the most dangerous and deadly op-
portunistic diseases for vulnerable people such as
children, the elderly and immunocompromised persons.
Their control becomes complex due to the emergence
of multiresistant bacteria and fungi to many conven-
tional antibiotics and antifungals [5–12]. Combined with
the scarcity of new drugs on the market in recent years,
this increase in bacterial and fungal resistance worldwide
is a major threat to public health. According to the 2014
WHO report, in Africa, there is strong resistance of
Escherichia coli to cephalosporins and third generation
fluoroquinolones; two types of essential and widely used
antibacterial drugs. It is also noted that 80 % of
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Staphylococcus aureus are resistant to methicillin
(MRSA) in some parts of this region [13]. Also, there is
an increased resistance to azoles such as fluconazole, the
antifungal drug of choice in many countries, and the re-
cently introduced antifungal agent, echinocandins [14].
In Ivory Coast, many cases of multidrug-resistant bac-
teria are reported [6–10]. According to Guessennd et al.
[15], the frequency of bacterial strains resistant to imipe-
nem increased from 1.9 % in 2005 to 5.9 % in 2009 and
that of bacteria producing beta-lactamase with extended
spectrum, from 5.3 % in 2005 to 16.8 % in 2009.
With the growing concern generated by the use of
drugs, both in therapy and in the food industry, there
has been in recent years an increase in interest in medi-
cinal plants [16]. Many medicinal plants have shown
their effectiveness against microbial infections across
Africa, particularly in Ivory Coast [17–20]. However, the
consumption pattern of chimpanzees, essentially com-
posed of plant organs, remains poorly explored in this
field. Chimpanzee remains morphologically and genetic-
ally the closest animal to humans, with 98 % of common
DNA [21]. This genetic proximity expressed at many
levels, including sharing with humans many zoonotic in-
fections such as candidiasis and other bacterial infec-
tions. However, it is known that chimpanzees in their
natural habitat are tolerant or resilient to SIV (Simian
immunodeficiency virus) while humans are vulnerable to
HIV, virus related to the simian virus [22, 23]. This toler-
ance or resilience of chimpanzee to SIV could be of gen-
etic origin but also due to the environment. Their
consumption pattern and feeding habit could indeed
greatly contribute to their health, because in captivity,
these animals develop many diseases [24]. It is recog-
nized in pathophysiology that the presence of HIV in the
body leads to a weakening of the immune system, pro-
moting the emergence of opportunistic infections such
as bacterial diseases and candidiasis [25].
A preliminary study carried out by Ahoua et al. [26]
on the therapeutic potential, including the antioxidant
capacity of eight plant species from Taï’s chimpanzee’s
diet and harvested in the same area, but different from
those investigated in this work, showed that these plants
have strong antioxidant activity.
Based on the “One Health” concept [26–29], that pro-
motes interdisciplinary and intersectorial collaborations
at the human-animal-environment interface, the current
study explores chimpanzees eating habits and behaviors
towards self-medication to identify plants with strong
antimicrobial potential able to play a role in the control
of infections in humans. These plants could bring added
value to the herbal medicine to solve health problems in
humans. The main objective is to assess the antimicro-
bial potential of plants falling within the diet of chim-
panzees in Tai National Park (Ivory Coast).
Methods
Selection of plant species
The plant species used for antimicrobial investigations
came from the diet of chimpanzees (Pan troglodytes ve-
rus) (Fig. 1) from Taï National Park (TNP), located in
the Southwestern region of Ivory Coast (Fig. 2). The re-
search authorization was provided by the Ministry of
Higher Education and Scientific Research of Ivory Coast
while access and work in the park was issued by the
Ministry of the Environment and Sustainable Develop-
ment through the Ivorian Parks and Reserves Office.
These plants were identified through direct observa-
tions in response to a previous study carried by N’Gues-
san [30] on Taï’s National Park chimpanzee’s diet. Many
criteria including the consumption frequency of plant
species, the consumed quantity and the duration of con-
sumption allowed us to select 27 plant species among
131 reported. These plants were harvested in TNP in
May and November 2012. The different parts harvested
were leaves, fruits (pericarp, mesocarp and endocarp)
and marrows (Fig. 3). Herbarium specimens were depos-
ited in the herbarium of Swiss Centre of Scientific Re-
search in Ivory Coast. Table 1 shows the different
harvested plants.
Extracts preparation
The samples were cleaned immediately after collec-
tion by washing them with water, dried under air at
18 °C for 3 weeks for the leaves and marrows. Fruits
were lyophilized and then pulverized. Afterwards,
20 g of plant powder were macerated successively in
200 ml of organic solvent (dichloromethane, ethyl
acetate and methanol) twice for 24 hours. Otherwise,
20 g of plant powder were macerated in 200 ml of
water in the same conditions. The macerates obtained
were then filtered and evaporated with a rotavapor at
40 °C. The methanol and aqueous extracts were then
lyophilized. Dichloromethane and ethyl acetate ex-
tracts were evaporated to dryness.
Assessment of the antimicrobial activity
Tested microorganisms
The antimicrobial activity was assessed against seven
strains of bacteria including Escherichia coli ATCC
25922, Escherichia coli CIP 54127AF, Pseudomonas aer-
uginosa CIP 103467, Pseudomonas aeruginosa ATCC
27853, Staphylococcus aureus sensitive to penicillin,
Staphylococcus aureus ATCC 25923, Staphylococcus aur-
eus CIP 4.83 and four strains of yeast (Candida albicans
(1), Candida albicans (2), Candida tropicalis and Can-
dida glabrata). These reference and clinical strains were
provided by the National Laboratory of Public Health of
Ivory Coast and the Microbiology Laboratory of Swiss
Centre of Scientific Research in Ivory Coast.
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The antimicrobial activity was evaluated according to
the protocol described by Koné et al. [18] using the agar
diffusion technique. Stock solutions of plant extracts
were prepared at 30 mg/ml in dimethyl sulfoxide
(DMSO) and at 1 mg/ml (in distilled water) for antibi-
otics (tetracycline and gentamicin) and antifungals (ny-
statin and amphotericin B).
Antibacterial activity
Sensitivity test Mueller-Hinton agar in Petri dishes
(thickness = 4 mm) were soaked with an inoculum
equivalent to 0.5 of McFarland. After drying, wells
(diameter = 6 mm) were made in the agar using sterile
Pasteur pipette. Fifty microliters (50 μl) of extract
(1.5 mg/ml) or antibiotic (0.025 mg/ml) was poured in
the wells. Plates were left at ambient laboratory
temperature for 15 to 30 min for a pre-diffusion of the
solutions, and then incubated at 37 °C for 18 h. After in-
cubation, the diameters (mm) of inhibition zones
were measured (Fig. 4). The tests were carried out
twice.
Determination of Minimum Inhibitory Concentration
(MIC) The extracts showing an inhibitory diameter of
at least 10 mm were selected to determine the mini-
mum inhibitory concentrations (MICs) using broth
microdilution method in 96-wells microplates [18].
The MIC is the lowest concentration at which the
visible growth of a strain was completely inhibited
(no visible turbidity in wells). The plant extracts were
solubilized in DMSO (30 mg/ml) and serially diluted
in Mueller-Hinton medium, from 1500 to 1.5 μg/ml.
The final concentrations were 25 to 0.05 μg/ml for
antibiotics. All the tested bacteria were used with an
initial inoculum of 3 × 106 bacteria/ml. The micro-
plates were incubated at 37 °C for 18 h.
Determination of Minimum Bactericidal Concen-
tration (MBC) MBC is the lowest concentration of
antibiotic or crude extract in which less than 0.01 % of
the initial inoculum survived after 18–24 h. Medium
from wells with no visible growth and from the initial in-
oculum (dilution 10−1, 10−2, 10−3; 10−4 and 10−5) were
plated on agar, and colonies counted. The value MBC/
MIC allowed to determine whether an extract was
bacteriostatic (MBC/MIC > 4) or bactericidal (MBC/
MIC < 4) [31].
Antifungal activity
Sensitivity test Tryptone Soya Agar in Petri dishes was
soaked with a yeast suspension. After drying, wells
(diameter = 6 mm) were made in the agar using a sterile
Pasteur pipette. A fraction (50 μl) of plant extract at
1.5 mg/ml or standard antifungal at 0.025 mg/ml was
poured in the wells. Plates were left at ambient labora-
tory temperature for 15 to 30 min for a pre-diffusion of
the solutions and then incubated at 30 °C for 48 to 72 h.
After incubation, the diameters (mm) of inhibition zones
a b
Fig. 1 Chimpanzees (Pan troglodytes verus) in Taï National Park. a Young chimpanzee eating Ficus fruits (Source: http://pin.primate.wisc.edu/
factsheets/french/chimpanzee); b-Group of chimpanzees (Source: http://www.sunservices.org/sun/index.php/tourisme/nos-parcs-et-reserves)
Fig. 2 Localization of Taï National Park on Ivory Coast map
(Source: wildchimps.org)
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Fig. 3 Example of plant organs consumed by chimpanzees. a Magnistipula butayei fruits; b Pycnanthus angolensis fruits; c Duboscia viridiflora fruits;
d Panda oleosa fruits; e Nauclea diderrichii leaves; f Ancistrophyllum secondiflorum marrows
Table 1 List of tested plant species
N° Plant species Family Plant part used
1 Afzelia bella Harms Leguminosae Leaves
2 Ancistrophyllum secundiflorum (P.Beauv.) G.Mann & H.Wendl. Arecaceae Marrow
3 Beilschmiedia mannii (Meisn.) Benth. & Hook. f. Lauraceae Whole fruits; Pericarp; Mesocarp; Endocarp
4 Calpocalyx aubrevillei Pellegr. Leguminosae Leaves
5 Chrysophyllum taiense Aubrév. & Pellegr. Sapotaceae Leaves
6 Coula edulis Baill. Olacaceae Fruits (Endocarp)
7 Dacryodes klaineana (Pierre) H.J.Lam. Burseraceae Fruits
8 Dialium aubrevillei Pellegr. Leguminosae Fruits
9 Dichapetalum pallidum (Oliv.) Engl. Dichapetalaceae Leaves
10 Dioscorea multiflora Mart. ex Griseb. Dioscoreaceae Leaves
11 Duboscia viridiflora (K.Schum.) Mildbr. Malvaceae Fruits
12 Glyphaea brevis (Spreng.) Monach. Tiliaceae Leaves
13 Halopegia azurea (K.Schum.) K.Schum. Marantaceae Marrow
14 Irvingia grandifolia (Engl.) Engl. Irvingiaceae Fruits
15 Keayodendron bridelioides Gilg & Mildbr. ex Hutch. & Dalziel Euphorbiaceae Leaves
16 Klainedoxa gabonensis Pierre ex Engl. Irvingiaceae Fruits (Pericarp)
17 Landolphia hirsuta (Hua) Pichon Apocynaceae Leaves
18 Magnistipula butayei De Wild. Chrysobalanaceae Fruits (Pericarp and endocarp)
19 Manniophyton fulvum Müll. Arg. Euphorbiaceae Leaves
20 Musanga cecropiodes R. Br. ex Tedlie Moraceae Leaves
21 Nauclea diderrichii (De Wild.) Merr. Rubiaceae Fruits; Leaves
22 Panda oleosa Pierre Pandaceae Fruits (Pericarp)
23 Parinari excelsa Sabine Chrysobalanaceae Fruits (Pericarp and endocarp)
24 Platysepalum hirsutum (Dunn) Hepper Leguminosae Leaves
25 Sarcophrynium brachystachys (Benth.) K. Schum. Marantaceae Marrow
26 Sterculia oblonga Mast. Sterculiaceae Leaves
27 Tristemma coronatum Benth. Melastomataceae Leaves
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were measured (Fig. 5). The tests were carried out twice
for result validation.
Determination of Minimum Inhibition Concentration
(MIC) Extracts with inhibitory diameters greater than or
equal to 10 mm, were selected to determine the mini-
mum inhibitory concentrations (MICs) by using a
microdilution method in liquid medium [16]. Plants ex-
tracts (1500 to 1.5 μg/ml) or nystatin and amphotericin
B, positive controls (25 to 0.05 μg/ml) were serially di-
luted in Sabouraud broth in microplates (96 wells). This
was followed by the addition of 50 μl of the inoculum to
each well. The microplates were incubated at 30 °C for
48 to 72 h. After incubation, 40 μl of chloride
methylthiazoyltetrazolium (MTT) at 0.2 mg/ml (in
water) were added to each well, and further incubated
again for 30 min at room temperature. The wells with
no growth of yeast were colored in yellow and the lowest
concentration (MIC) was determined [32]. The experi-
ment was performed in duplicate in the same plate and
tests were repeated twice.
Statistical analysis
Microsoft Access 2007 was used for data entry. Data
were then exported to Excel for analysis. The software
STATISTICA 7.1 was used for data analysis [33]. Re-
sults were presented as mean ± SD of duplicate exper-
iments. One-way analysis of variance (ANOVA) was
used to compare extract’s inhibitory diameters. Sig-
nificant differences between extracts were determined
at P < 0.05. The least significant difference (LSD) be-
tween extracts was performed by the HDS test of
Tukey.
Results and discussion
The results of this study showed that out of the 132
tested extracts, 24 (18 %) were active against bacteria
(Tables 2 and 3) and 6 (5 %) against fungi (Table 4). The
inhibition zones diameters were between 10 and 20 mm.
The MICs values ranged between 23 and 750 μg/ml for
extracts and between 0.10 and 3 μg/ml for standards
(0.10 to 3 μg/ml for gentamicin; 0.20 to 1.6 μg/ml for
tetracycline). The active extracts were bactericidals and
a b
Fig. 4 Inhibitory diameters of some ethyl acetate extracts on two bacteria Pseudomonas aeruginosa CIP 103467 (a) and Staphylococcus aureus ATCC
25923 (b) 24 =Musanga cecropioides; 25 = Landolphia hirsuta; 26 = Endocarp of Beilschmiedia mannii fruits; 28 =Duboscia viridiflora; 31 = Klainedoxa
gabonensis; G = gentamicin
a b
Fig. 5 Inhibitory diameters of some ethyl acetate extracts on two yeasts Candida albicans ATCC 10231 (a) and Candida glabrata (b). 1 =Dacryodes
klaineana; 2 = Chrysophyllum taiense; 3 = Pericarp of Panda oleosa fruits; 4 =Dichapetalum pallidum; 5 = Mesocarp of Beilschmiedia mannii fruits;
29 = Pericarp of Beilschmiedia mannii fruits; 30 = Endocarp of Parinari excelsa fruits; 31 = Klainedoxa gabonensis
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bacteriostatics (Table 3). A MIC value of 188 μg/ml or
lower was considered a reasonable cut-off point for
crude extracts.
In short, eight extracts were the most active show-
ing MICs below this limit. These extracts showed ac-
tivities against more than two strains of bacteria with
low MIC values, namely the ethyl acetate extract of
the leaves from C. aubrevillei (23–188 μg/ml), the
ethyl acetate and dichloromethane extracts of the
fruits mesocarp from B. mannii (94–188 μg/ml and
47–94 μg/ml, respectively), the ethyl acetate extract of
the fruits pericarp from K. gabonensis (47–188 μg/ml)
and the methanol extract of the whole fruits from B.
mannii (94–375 μg/ml). These extracts were followed
by those with the methanol extract of the fruits
mesocarp from B. mannii (94–188 μg/ml) and the
ethyl acetate extracts from the whole fruits of B.
mannii (47–188 μg/ml) and the leaves of T. corona-
tum (47–188 μg/ml). For most of these plants, mainly
B. mannii and C. aubrevillei, it is the first time that
Table 2 Inhibitory diameters (mm) of extracts on tested bacteria*
Bacteria
Plant species Plant parts used Extracts S. a. CIP
4.83












Pericarp DCM 15 ± 0.5cd 7 ± 0.5lm 0 0 0 9 ± 0.0gj 0
Mesocarp DCM 15 ± 1.0cd 14 ± 1.0c 13 ± 2.0fg 0 0 12 ± 1.5cf 0
EtOAc 12 ± 0.5e 12 ± 0.5de 10 ± 0.0hj 0 0 13 ± 0.5ce 0
MeOH 10 ± 0.5fg 11 ± 0.5eg 9 ± 0.5jk 0 0 10 ± 0.0fi 0
Aqueous 0 10 ± 0.0eh 0 0 0 0 0
Endocarp DCM 0 9 ± 0.5hk 0 0 0 10 ± 0.0fi 0
Whole fruits EtOAc 10 ± 0.0f 11 ± 0.0df 9 ± 0.5jk 0 0 11 ± 0.5eh 0
MeOH 10 ± 1.0f 11 ± 0.0df 11 ± 0.5hi 0 0 11 ± 0.0eh 0
Chrysophyllum
taiense
Leaves EtOAc 0 11 ± 0.5eg 0 0 0 11 ± 0.5eh 0
MeOH 8 ± 0.5ij 10 ± 0.0eh 9 ± 0.0ik 0 0 10 ± 0.5fj 0
Nauclea diderrichii Leaves DCM 0 13 ± 0.5cd 0 0 0 14 ± 2.5c 0
MeOH 10 ± 0.5fg 10 ± 0.0eh 9 ± 0.0ik 0 0 9 ± 0.5fj 0
Manniophyton
fulvum
Leaves MeOH 0 9 ± 0.50hk 15 ± 0.5ef 0 0 9 ± 0.5hj 0
Calpocalyx
aubrevillei
Leaves EtOAc 13 ± 0.5e 13 ± 0.5cd 12 ± 0.5gh 0 0 13 ± 0.0cd 0
MeOH 9 ± 0.5gi 11 ± 0.5eg 9 ± 0.0ik 0 0 10 ± 1.0fj 0
Dacryodes
klaineana
Fruits EtOAc 0 0 18 ± 0.5cd 0 0 9 ± 1.5gj 0
Landolphia
hirsuta
Leaves MeOH 9 ± 0.5gi 10 ± 0.5fi 7 ± 0.5l 0 0 10 ± 0.5fj 0
Platysepalum
hirsutum
Leaves EtOAc 0 9 ± 0.5fi 0 0 0 10 ± 0.0fi 0
MeOH 9 ± 0.5gi 10 ± 0.5fi 8 ± 0.5kl 0 0 10 ± 0.5fj 0
Klainedoxa
gabonensis
Pericarp EtOAc 15 ± 0.5cd 10 ± 0.0eh 16 ± 0.0de 0 0 11 ± 0.0dg 0
Sterculia oblonga Leaves DCM 0 11 ± 0.0df 0 0 0 0 0
Magnistipula
butayei
Pericarp DCM 15 ± 0.0cd 9 ± 0.0gj 9 ± 0.5ijk 0 0 9 ± 1.5gj 0
Tristemma
coronatum
Leaves EtOAc 16 ± 1.0c 9 ± 0.5fi 19 ± 1.0c 0 0 10 ± 0.5fj 0
MeOH 0 9 ± 0.0fi 17 ± 1.5d 0 0 8 ± 0.0ij 0
Gentamicin 20 ± 0.5b 22 ± 1.5a 22 ± 0.5b 21 ± 2.5a 0 29 ± 1.0a 29 ± 1.5a
Tetracycline 23 ± 0.5a 19 ± 1.0b 30 ± 1.5a 17 ± 1.0b 0 21 ± 0.5b 24 ± 1.0b
F 432.11 268.08 290.02 97.082 176.88 423.89
P < 0.001
*: Mean ± SD of two replicates; DCM: Dichloromethane; EtOAc: Ethyl Acetate; MeOH: Methanol; S. a.: Staphylococcus; E: Escherichia; P. a.: Pseudomonas aeruginosa;
ATCC: American Type Culture Collection; CIP: Centre Institut Pasteur; Sen: Sensitive; F: Fisher statistical; P: Probability; Values with the same superscript letter are
not significantly different (P < 0.001)
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Table 3 Antibacterial powers of active extracts
Bacteria
Plant species Plant part used Extracts S. a. CIP 4.83 S. a. Sen S. a. ATCC 25923 P. a. CIP 103467
















EtOAc MIC 188 23 23 47
MBC 750 375 375 375
MBC/MIC 4 16 16 8
APw bact bacstat bacstat bacstat
Beilschmiedia mannii Mesocarp DCM MIC 47 47 47 94
MBC 47 94 1500 94
MBC/MIC 1 2 32 1
APw bact bact bacstat bac
EtOAc MIC 188 188 94 94
MBC >1500 375 375 375
MBC/MIC >8 2 4 4
APw bacstat bact bact bact
MeOH MIC 94 188 >1500 188
MBC >1500 >1500 >1500
MBC/MIC >16 >8 >8
APw bacstat bacstat bacstat








EtOAc MIC >1500 >1500 >1500 187
MBC 750
MBC/MIC 4
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Table 3 Antibacterial powers of active extracts (Continued)
APw bact




Beilschmiedia mannii Whole fruits MeOH MIC 94 375 94 188
MBC 375 750 >1500 750
MBC/MIC 4 2 >16 4
APw bact bact bacstat bact
EtOAc MIC 188 47 >1500 188
MBC >1500 750 1500
MBC/MIC >8 16 8
APw bacstat bacstat bacstat








Tristemma coronatum Leaves EtOAc MIC 188 >1500 47 188
MBC >1500 1500 750
MBC/MIC >8 32 4
APw bacstat bacstat bact
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their antimicrobial activity is demonstrated. However,
B. mannii was previously studied for other activities.
Thus, the fruits of B. mannii were reported to have
low antioxidant property [34]. Moreover, antibacterial
activity of related species of B. mannii was screened.
So, Fankam et al. [35] showed that the methanol ex-
tract of fruits from Beilschmiedia obscura exhibited
antimicrobial activity on various bacterial strains in-
cluding P. aeruginosa, a multiresistant bacteria. Com-
pounds isolated from the stem bark of Beilschmiedia
anacardioides showed activity against Bacillus subtilis,
Micrococcus luteus and Streptococcus faecalis [36].
Phytochemical studies of several species of Beilsch-
miedia genus revealed the presence of antibacterial
compounds such as alkaloids [37], flavonoids [38, 39]
and phenolics, and related compounds [40]. These
compounds could explain the bactericidal activity of
B. mannii where inhibitory diameters (10–15 mm)
found with the extracts were the closest to those of
gentamicin (20–29 mm) and tetracycline (17–30 mm).
The activities observed in various species of Beilsch-
miedia showed that this genus has the potential to
fight against bacteria and could be exploited to search
for potential antibacterial molecules.
Concerning C. aubrevillei, no biological and phyto-
chemical studies were reported on this species. However,
it was reported that this plant is also consumed by Bos-
sou chimpanzees in Guinea [41]. On the opposite, in the
western region of Ivory Coast, it fits in the diet of people
[42]. According to the results obtained in this study, this
plant has mainly bacteriostatic effects with inhibitory
diameters mainly around 13 mm and MICs values be-
tween 23 and 188 μg/ml.
Nevertheless, none of the tested extracts showed activ-
ity against the two strains of E. coli and that of P. aerugi-
nosa ATCC 27853. Gentamicin and tetracycline showed
activities (17–30 mm) on all strains.
The methanol extract of the leaves from T. coronatum
and the ethyl acetate extracts from K. gabonensis fruits
showed activity against C. tropicalis, C. albicans (1) and
C. glabrata (Table 4). The ethyl acetate extract of the
leaves from T. coronatum and the fruits from D. klai-
neana were effective against C. albicans (1) and C. glab-
rata while the methanolic extracts of the leaves from M.
fulvum and the marrow of Ancistrophyllum secundi-
florum were only active against C. albicans (1) and C.
glabrata, respectively. Amphotericin B and nystatin did
not show any activity against C. albicans (2), while the
ethyl acetate extracts from D. klaineana fruits and the
fruits pericarp of K. gabonensis showed low activity in
this strain with respectively 6 and 8 mm inhibitory
diameter. The MICs values of the active extracts ranged
between 188 and 1500 μg/ml and were greater or equal
to 25 μg/ml for the positive controls (>25 μg/ml for
amphotericin B; ≥ 25 μg/ml for nystatin) (Table 5). The
methanol and ethyl acetate extracts of the leaves from T.
coronatum as well as the ethyl acetate extract from the
pericarp of K. gabonensis were the most active.
The ethyl acetate extract from K. gabonensis fruits and
from the leaves of T. coronatum showed an activity
against fungi as well as, bacteria and were mainly bacte-
riostatics. These two plant extracts showed the greatest
Table 3 Antibacterial powers of active extracts (Continued)




Klainedoxa gabonensis Pericarp EtOAc MIC 188 94 47 188
MBC 1500 750 750 750
MBC/MIC 8 8 16 4
APw bacstat bacstat bacstat bact
Gentamicin MIC 0.10 0.8 0.10 3
MBC 0.4 0.8 0.10 3
MBC/MIC 4 1 1 1
APw bact bact bact bact
Tetracycline MIC 0.8 0.2 0.4 1.6
MBC 6 6 0.4 3
MBC/MIC 8 30 1 2
APw bacstat bacstat bact bact
MIC minimal inhibitory concentration (μg/ml); CMB minimum bactericidal concentration (μg/ml); APw antibacterial power; Bacstat bacteriostatic; Bact bactericidal;
S. a. Staphylococcus; P. a. Pseudomonas aeruginosa; ATCC American type culture collection; CIP Centre Institut Pasteur; Sen sensitive
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inhibitory diameters on bacteria. For T. coronatum it is
also the first time, to our knowledge, that the antimicro-
bial activity is reported. This plant showed the greatest
inhibitory diameters specifically on S. aureus CIP 4.83
(16 mm) and S. aureus ATCC 25923 (17–19 mm) and
also yeasts (11–13 mm) with MICs values between 375
and 1500 μg/ml. K. gabonensis was already studied for
its antimicrobial properties. Wansi et al. [43] showed the
effect of some compounds isolated from the stem bark
of this plant, in particular ellagic acid, 3,3′-dimethyl
Table 4 Inhibitory diameters (mm) of active extracts on Candida strains*
Fungi
Plant species Plant part used Extracts C. albicans (1) C. albicans (2) C. tropicalis C. glabrata
Ancistrophyllum secundiflorum Marrow DCM 0 0 0 0
EtOAc 0 0 0 0
MeOH 0 0 0 11 ± 0.5c
Aqueous 0 0 0 0
Manniophyton fulvum Leaves DCM 0 0 0 0
EtOAc 0 0 0 0
MeOH 12 ± 0.0b 0 0 0
Aqueous 0 0 0 0
Dacryodes klaineana Fruits DCM 0 0 0 0
EtOAc 12 ± 0.5bc 6 ± 0.0c 0 15 ± 0.5a
MeOH 0 0 0 0
Aqueous 0 0 0 0
Klainedoxa gabonensis Pericarp DCM 0 0 0 0
EtOAc 12 ± 0.0b 8 ± 0.5a 10 ± 0.0c 10 ± 0.0c
MeOH 0 0 0 0
Aqueous 0 0 0 0
Tristemma coronatum Leaves DCM 0 0 0 0
EtOAc 12 ± 0.0b 0 0 13 ± 0.5b
MeOH 12 ± 0.5bc 0 11 ± 0.0b 12 ± 0.0b
Aqueous 0 0 0 0
Amphotericin B 14 ± 0.0a 0 16 ± 0.5a 15 ± 0.0a
Nystatine 11 ± 1.0c 0 11 ± 1.0b 13 ± 0.5b
F 495.94 993.87 404.49 1091.4
P < 0.001
*: Mean ± SD of two replicates; DCM: Dichloromethane; EtOAc: Ethyl Acetate; MeOH: Methanol; C: Candida; F: Fisher statistical; P: Probability; Values with the same
superscript letter are not significantly different (P < 0.001)
Table 5 Minimal Inhibitory Concentration (MIC) of active extracts on yeasts
MIC (μg/ml)
Plant species Plant part used Extracts C. albicans (1) C. tropicalis C. glabrata
Manniophyton fulvum Leaves MeOH 1500 nd nd
Tristemma coronatum Leaves EtOAc 750 nd 375
MeOH >1500 375 375
Ancistrophyllum secundiflorum Marrow MeOH nd nd >1500
Dacryodes klaineana Fruits EtOAc 188 nd nd
Klainedoxa gabonensis Pericarp EtOAc 750 188 750
Amphotericin B >25 >25 >25
Nystatine 25 >25 >25
EtOAc ethyl acetate, MeOH methanol, C Candida, nd non determined
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ether ellagic acid, gallic acid and the methyl gallate on
various sources of microbes including E. coli, S. aureus
and C. albicans. These compounds could be the basis of
the bacteriostatic effects or the antifungal activities
(MIC between 188 and 750 μg/ml) of the studied fruits
in this work. In Cameroon, K. gabonensis is used to treat
various diseases including bacterial diseases [44]. On the
opposite, in Congo, it is used by traditional healers for
the treatment of dermatitis incurable by modern medi-
cine [45]. In Ivory Coast, any indication of the thera-
peutic use of this plant species has not yet been
reported. Therefore, the results obtained in this study
with the fruits of this plant confirm the traditional uses
already described above.
Conclusion
The results of this study showed that the plants con-
sumed by chimpanzees of TNP possess strong anti-
microbial activity. The use of plants by chimpanzees
confirms the self-medication in the natural setting.
These plants are poorly exploited in various areas, in-
cluding their antimicrobial potential. Faced with the re-
sistance of microorganisms to various conventional
drugs, it would be interesting to explore the feeding be-
havior of primates in order to make profits. These plants
could help to fight efficiently against several pathologies
especially opportunistic diseases. Interestingly, promising
plants such as T. coronatum and B. mannii were identi-
fied. The extracts of those plants could be used for fur-
ther investigation in human medicine. We plan to
investigate other biological activities of these species and
their phytochemicals.
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